114 related articles for article (PubMed ID: 33798946)
1. PML-II recruits ataxin-3 to PML-NBs and inhibits its deubiquitinating activity.
Zhang Y; Shao AW; Tang J; Geng Y
Biochem Biophys Res Commun; 2021 May; 554():186-192. PubMed ID: 33798946
[TBL] [Abstract][Full Text] [Related]
2. Swine Promyelocytic Leukemia Isoform II Inhibits Pseudorabies Virus Infection by Suppressing Viral Gene Transcription in Promyelocytic Leukemia Nuclear Bodies.
Yu C; Xu A; Lang Y; Qin C; Wang M; Yuan X; Sun S; Feng W; Gao C; Chen J; Zhang R; Tang J
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641476
[TBL] [Abstract][Full Text] [Related]
3. Contribution of the C-terminal regions of promyelocytic leukemia protein (PML) isoforms II and V to PML nuclear body formation.
Geng Y; Monajembashi S; Shao A; Cui D; He W; Chen Z; Hemmerich P; Tang J
J Biol Chem; 2012 Aug; 287(36):30729-42. PubMed ID: 22773875
[TBL] [Abstract][Full Text] [Related]
4. Identification of RNF168 as a PML nuclear body regulator.
Shire K; Wong AI; Tatham MH; Anderson OF; Ripsman D; Gulstene S; Moffat J; Hay RT; Frappier L
J Cell Sci; 2016 Feb; 129(3):580-91. PubMed ID: 26675234
[TBL] [Abstract][Full Text] [Related]
5. The translation initiation factor 3 subunit eIF3K interacts with PML and associates with PML nuclear bodies.
Salsman J; Pinder J; Tse B; Corkery D; Dellaire G
Exp Cell Res; 2013 Oct; 319(17):2554-65. PubMed ID: 24036361
[TBL] [Abstract][Full Text] [Related]
6. Role of nuclear bodies in apoptosis signalling.
Krieghoff-Henning E; Hofmann TG
Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765
[TBL] [Abstract][Full Text] [Related]
7. Viral disruption of promyelocytic leukemia (PML) nuclear bodies by hijacking host PML regulators.
Frappier L
Virulence; 2011; 2(1):58-62. PubMed ID: 21217204
[TBL] [Abstract][Full Text] [Related]
8. The promyelocytic leukemia protein isoform PML1 is an oncoprotein and a direct target of the antioxidant sulforaphane (SFN).
Alhazmi N; Pai CP; Albaqami A; Wang H; Zhao X; Chen M; Hu P; Guo S; Starost K; Hajihassani O; Miyagi M; Kao HY
Biochim Biophys Acta Mol Cell Res; 2020 Aug; 1867(8):118707. PubMed ID: 32243901
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of component exchange at PML nuclear bodies.
Weidtkamp-Peters S; Lenser T; Negorev D; Gerstner N; Hofmann TG; Schwanitz G; Hoischen C; Maul G; Dittrich P; Hemmerich P
J Cell Sci; 2008 Aug; 121(Pt 16):2731-43. PubMed ID: 18664490
[TBL] [Abstract][Full Text] [Related]
10. The Role of Non-Specific Interactions in Canonical and ALT-Associated PML-Bodies Formation and Dynamics.
Fonin AV; Silonov SA; Shpironok OG; Antifeeva IA; Petukhov AV; Romanovich AE; Kuznetsova IM; Uversky VN; Turoverov KK
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072343
[TBL] [Abstract][Full Text] [Related]
11. The herpesvirus associated ubiquitin specific protease, USP7, is a negative regulator of PML proteins and PML nuclear bodies.
Sarkari F; Wang X; Nguyen T; Frappier L
PLoS One; 2011 Jan; 6(1):e16598. PubMed ID: 21305000
[TBL] [Abstract][Full Text] [Related]
12. Degron capability of the hydrophobic C-terminus of the polyglutamine disease protein, ataxin-3.
Blount JR; Johnson SL; Libohova K; Todi SV; Tsou WL
J Neurosci Res; 2020 Oct; 98(10):2096-2108. PubMed ID: 32643791
[TBL] [Abstract][Full Text] [Related]
13. PML isoforms: a molecular basis for PML pleiotropic functions.
Uggè M; Simoni M; Fracassi C; Bernardi R
Trends Biochem Sci; 2022 Jul; 47(7):609-619. PubMed ID: 35232626
[TBL] [Abstract][Full Text] [Related]
14. Involvement of PML-I in reformation of PML nuclear bodies in acute promyelocytic leukemia cells by leptomycin B.
Wang C; Su L; Shao YM; Chen WZ; Bu N; Hao R; Ma LY; Hussain L; Lu XY; Wang QQ; Naranmandura H
Toxicol Appl Pharmacol; 2019 Dec; 384():114775. PubMed ID: 31669778
[TBL] [Abstract][Full Text] [Related]
15. PML nuclear body-residing proteins sequentially associate with HPV genome after infectious nuclear delivery.
Guion L; Bienkowska-Haba M; DiGiuseppe S; Florin L; Sapp M
PLoS Pathog; 2019 Feb; 15(2):e1007590. PubMed ID: 30802273
[TBL] [Abstract][Full Text] [Related]
16. PML nuclear bodies are recruited to persistent DNA damage lesions in an RNF168-53BP1 dependent manner and contribute to DNA repair.
Vancurova M; Hanzlikova H; Knoblochova L; Kosla J; Majera D; Mistrik M; Burdova K; Hodny Z; Bartek J
DNA Repair (Amst); 2019 Jun; 78():114-127. PubMed ID: 31009828
[TBL] [Abstract][Full Text] [Related]
17. PML-associated repressor of transcription (PAROT), a novel KRAB-zinc finger repressor, is regulated through association with PML nuclear bodies.
Fleischer S; Wiemann S; Will H; Hofmann TG
Exp Cell Res; 2006 Apr; 312(6):901-12. PubMed ID: 16412420
[TBL] [Abstract][Full Text] [Related]
18. The Human CMV IE1 Protein: An Offender of PML Nuclear Bodies.
Scherer M; Schilling EM; Stamminger T
Adv Anat Embryol Cell Biol; 2017; 223():77-94. PubMed ID: 28528440
[TBL] [Abstract][Full Text] [Related]
19. New Evidence of the Importance of Weak Interactions in the Formation of PML-Bodies.
Fonin AV; Silonov SA; Fefilova AS; Stepanenko OV; Gavrilova AA; Petukhov AV; Romanovich AE; Modina AL; Zueva TS; Nedelyaev EM; Pleskach NM; Kuranova ML; Kuznetsova IM; Uversky VN; Turoverov KK
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163537
[TBL] [Abstract][Full Text] [Related]
20. Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies.
Kumada S; Uchihara T; Hayashi M; Nakamura A; Kikuchi E; Mizutani T; Oda M
J Neuropathol Exp Neurol; 2002 Nov; 61(11):984-91. PubMed ID: 12430715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
